ALternate Site Cardiac ReSYNChronization (ALSYNC) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.
Also called NCT01277783
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 138 participants
- Registry
-
NCT01277783
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Canada, France, Hungary, Italy, Netherlands, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01277783. Allocation not applicable; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2019-06-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ALternate Site Cardiac ReSYNChronization (ALSYNC) Study
- Acronym
- ALSYNC
- Condition
- Heart Failure
- Intervention (Device)
- Endocardial Left Ventricular pacing
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct01277783- Content hash
a1e665935f2d33957b9181fb4d0da0851a84dcc9a714e099265ae7db64f3c799